WHO Pharmaceuticals Newsletter 1997, No. 11&12
(1997; 24 pages)
Table of Contents
Open this folder and view contentsRegulatory actions
Open this folder and view contentsDrug surveillance
Open this folder and view contentsNew developments
Open this folder and view contentsMedical devices
Open this folder and view contentsGeneral information
Close this folderVeterinary medicine
View the documentChlortetracycline and tetracycline in veterinary medicines - revised package inserts: Germany
View the documentEprinomectin - approved for parasite control in cattle: United States of America
View the documentPharmacovigilance of veterinary medicines - draft guidelines: EC
 

Chlortetracycline and tetracycline in veterinary medicines - revised package inserts: Germany

Germany. The Federal Institute for Health Protection of Consumers and Veterinary Medicine has revised the package inserts for veterinary products containing chlortetracycline or tetracycline for the treatment of infectious gastro-intestinal diseases.

Chlortetracycline. The section on dosage will now include the following statement:

“Note. Prior to the administration of chlortetracycline, the sensitivity of the pathogen is to be established (antibiogram). This applies especially to suspected infections with Escherichia coli and Salmonella typhimurium where already very high rates of tetracycline resistance have been observed.”

Tetracycline. The section on directions for dosage, type and duration of treatment will now include the following statement:

“Note. As very high rates of tetracycline resistance have already been observed, especially in causative agents of gastro-intestinal infections of farm animals, the product should be used only after establishment of their sensitivity (antibiogram).”

Reference: Notification from the Federal Institute for Health Protection of Consumers and Veterinary Medicine, 13 June 1997.

.
.

to previous section to next section
 

Last updated: May 3, 2013